Story
Innovent Biologics Shares Hit Record High on Strong H1 Earnings, Ambitious Outlook

Innovent Biologics (1801.HK) shares surged to a record high on Wednesday, propelled by a robust first-half 2026 earnings report that highlighted significant growth in revenue and profitability. The biopharmaceutical company's strong performance and newly announced strategic vision resonated with investors, making it the top performer on the Hang Seng index for the day.
First-Half Financials Drive Rally
According to its interim results, Innovent's financial performance for the first six months of 2026 showed substantial year-over-year growth. The positive figures underscore the company's successful commercial execution across its product lines.
Key financial highlights include:
- Total Revenue: RMB 8.6 billion, a 45% increase from the same period in 2025.
- Product Revenue: RMB 8.2 billion, up 57%, indicating strong commercial momentum.
- IFRS Net Profit: RMB 1.3 billion, a 50% year-over-year jump.
- Cash Position: A healthy RMB 30.2 billion.
AdMarket Reaction and Strategic Outlook
In response to the strong results, Innovent's stock climbed nearly 13% to a new record of HK$112.7 during Wednesday's trading session. This performance significantly outpaced the broader Hang Seng index, which posted a modest gain of 0.8%.
Looking ahead, the company also outlined a new 2030 strategic vision. Innovent is targeting annual revenues of RMB 35–40 billion by the end of the decade, signaling a decisive shift from its current focus on the Chinese market toward becoming a global biopharmaceutical platform. This long-term strategy suggests a focus on expanding its international presence and market access.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.